Whilst not licensed as an antihypertensive agent, tirzepatide's blood pressure-lowering effectsprimarily mediated through weight loss and metabolic improvementsoffer additional cardiovascular benefits for patients with type 2 diabetes or obesity
The recommended dose is 1,000 to 2,000 mg of combined EPA and DHA daily
alcohol exposure to environmental toxins (pollution, pesticides, plastics) high or chronic emotional stress circadian rhythm dysregulation (poor sleep) lack of exercise infections lack of antioxidant intake Important note
More frequent injections would increase your total weekly drug exposure and carry unknown risks for side effects, hypoglycemia, and gastrointestinal complications
Some people may need to stay on semaglutide longer if they are at risk of regaining a lot of weight or if they have health problems related to obesity, like type 2 diabetes, high blood pressure, or sleep apnea
Human autoimmune diseases: a comprehensive update